Detalhe da pesquisa
1.
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
Am J Gastroenterol
; 114(2): 258-266, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30538290
2.
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review.
J Intern Med
; 286(3): 290-298, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124596
3.
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment.
J Viral Hepat
; 25(11): 1331-1340, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851204
4.
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort.
J Viral Hepat
; 24(1): 13-16, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27905669
5.
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.
J Viral Hepat
; 24(6): 454-463, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27976461
6.
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
J Viral Hepat
; 24(10): 858-864, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370880
7.
Reply.
Clin Gastroenterol Hepatol
; 19(3): 619, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248100
8.
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.
Br J Cancer
; 112(1): 69-76, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25314061
9.
Adaptive response in hepatitis B virus infection.
J Viral Hepat
; 21(5): 305-13, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24674098
10.
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
J Viral Hepat
; 20(4): e115-23, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23490379
11.
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.
Am J Transplant
; 12(3): 694-705, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22233522
12.
Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury.
Ann Oncol
; 28(3): 671-672, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993797
13.
Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
J Viral Hepat
; 19 Suppl 1: 52-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22233415
14.
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
J Viral Hepat
; 19(9): 623-34, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22863266
15.
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients.
J Viral Hepat
; 18(10): e468-74, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914065
16.
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography.
Ultraschall Med
; 32(2): 167-75, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321842
17.
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.
J Viral Hepat
; 17(5): 360-6, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19758274
18.
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.
Minerva Med
; 101(6): 373-83, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21196896
19.
Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.
J Viral Hepat
; 16(1): 28-35, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18761603
20.
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
J Viral Hepat
; 15(6): 442-8, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18221304